Skip to content

KoreaN Cohort Study for Outcome in Patients With Kidney Transplantation (KNOW-KT)

KoreaN Cohort Study for Outcome in Patients With Kidney Transplantation : A 9-year Longitudinal Cohort Study of the Kidney Transplantation (KNOW-KT)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02042963
Acronym
KNOW-KT
Enrollment
1000
Registered
2014-01-23
Start date
2012-03-31
Completion date
Unknown
Last updated
2014-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complications After Kidney Transplant, Kidney Transplant Recipients

Keywords

The cohort of Asian kidney transplant recipients, The cohort of metabolic complication after kidney transplant, The biorepository of Asian kidney transplant recipients

Brief summary

KNOW-KT (KoreaN cohort study for Outcome in patients With KT: A 9-year Longitudinal cohort study of the Korean adult KT patients), funded by Korea Center for Disease Control and Prevention (KCDC) was established in 2012 by a group of transplant physicians, transplant surgeons, nephrologists, epidemiologists, and biostatisticians in Korea. We aimed to establish an adult KT cohort, to investigate the renal allograft outcomes, mortality, complications, and to explore traditional or nontraditional risk factors for morbidity and mortality. We established a bio-bank to integrate clinical and biological information. Here, we report design and method of the KNOW-KT.

Interventions

None listed

Sponsors

Asan Medical Center
CollaboratorOTHER
Chonbuk National University Medical School
CollaboratorUNKNOWN
Gachon University Gil Medical Center
CollaboratorOTHER
Keimyung University Dongsan Medical Center
CollaboratorOTHER
Korea University
CollaboratorOTHER
Kyungpook National University Hospital
CollaboratorOTHER
Samsung Medical Center
CollaboratorOTHER
Medical Research Collaborating Center, Seoul, Korea
CollaboratorOTHER
Yonsei University
CollaboratorOTHER
Seoul National University College of Medicine
CollaboratorUNKNOWN
Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Recipients and Donors of kidney transplant

Exclusion criteria

* Multi-organ transplant recipients

Design outcomes

Primary

MeasureTime frameDescription
overall mortality9 years
Allograft survival9 yearsdefined as re-transplant or initiation of maintenance dialysis

Secondary

MeasureTime frameDescription
Acute Rejection9 years
cardiovascular event9 yearsAcute Myocardial Infarction Revascularization : PCI or CABG Stroke Admission from Congestive heart failure
Quality of Life2 years
New onset of diabetes after transplant9 years
Albuminuria9 years

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 30, 2026